NO996352L - Kappaagonistforbindelser, farmasøytiske formuleringer og metode for forhindring og behandling av kløe med disse - Google Patents
Kappaagonistforbindelser, farmasøytiske formuleringer og metode for forhindring og behandling av kløe med disseInfo
- Publication number
- NO996352L NO996352L NO996352A NO996352A NO996352L NO 996352 L NO996352 L NO 996352L NO 996352 A NO996352 A NO 996352A NO 996352 A NO996352 A NO 996352A NO 996352 L NO996352 L NO 996352L
- Authority
- NO
- Norway
- Prior art keywords
- preventing
- pharmaceutical formulations
- agonist compounds
- kappa agonist
- treating itching
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/891,833 US5763445A (en) | 1996-03-08 | 1997-07-14 | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
PCT/US1998/012769 WO1999003468A1 (en) | 1997-07-14 | 1998-06-19 | Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
Publications (2)
Publication Number | Publication Date |
---|---|
NO996352D0 NO996352D0 (no) | 1999-12-20 |
NO996352L true NO996352L (no) | 2000-03-13 |
Family
ID=25398903
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO996352A NO996352L (no) | 1997-07-14 | 1999-12-20 | Kappaagonistforbindelser, farmasøytiske formuleringer og metode for forhindring og behandling av kløe med disse |
NO20054249A NO20054249L (no) | 1997-07-14 | 2005-09-14 | Anvendelse av komposisjon for fremstilling av et farmasoytisk preparat for forhindring eller behandling av kloe hos en pasient |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20054249A NO20054249L (no) | 1997-07-14 | 2005-09-14 | Anvendelse av komposisjon for fremstilling av et farmasoytisk preparat for forhindring eller behandling av kloe hos en pasient |
Country Status (12)
Country | Link |
---|---|
US (7) | US5763445A (no) |
EP (1) | EP0998281A1 (no) |
JP (1) | JP2001510154A (no) |
KR (1) | KR20010021853A (no) |
AU (1) | AU725232B2 (no) |
BR (1) | BR9810712A (no) |
CA (1) | CA2289055A1 (no) |
IL (1) | IL132388A0 (no) |
NO (2) | NO996352L (no) |
NZ (2) | NZ513889A (no) |
WO (1) | WO1999003468A1 (no) |
ZA (1) | ZA986208B (no) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6190691B1 (en) | 1994-04-12 | 2001-02-20 | Adolor Corporation | Methods for treating inflammatory conditions |
US5962477A (en) * | 1994-04-12 | 1999-10-05 | Adolor Corporation | Screening methods for cytokine inhibitors |
US5849761A (en) * | 1995-09-12 | 1998-12-15 | Regents Of The University Of California | Peripherally active anti-hyperalgesic opiates |
US6573282B1 (en) | 1995-09-12 | 2003-06-03 | Adolor Corporation | Peripherally active anti-hyperalgesic opiates |
US5763445A (en) * | 1996-03-08 | 1998-06-09 | Adolor Corporation | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
US6303611B1 (en) * | 1996-03-08 | 2001-10-16 | Adolor Corporation | Kappa agonist compounds and pharmaceutical formulations thereof |
US6750216B2 (en) | 1996-03-08 | 2004-06-15 | Adolor Corporation | Kappa agonist compounds and pharmaceutical formulations thereof |
US6239154B1 (en) | 1996-03-08 | 2001-05-29 | Adolor Corporation | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
WO1999003459A1 (en) * | 1997-07-14 | 1999-01-28 | Adolor Corporation | Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
WO1999032096A1 (en) * | 1997-12-22 | 1999-07-01 | Alza Corporation | Novel formulations for the transdermal administration of asimadoline |
ES2217742T3 (es) | 1998-04-01 | 2004-11-01 | Cardiome Pharma Corp. | Compuestos de amino ciclohexil eter y usos del mismo. |
WO1999065932A1 (en) | 1998-06-18 | 1999-12-23 | Sepracor, Inc. | Tetrapeptides, analogs and peptidomimetics which bind selectively mammalian opioid receptors |
US7507545B2 (en) | 1999-03-31 | 2009-03-24 | Cardiome Pharma Corp. | Ion channel modulating activity method |
US7919119B2 (en) * | 1999-05-27 | 2011-04-05 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
US6383511B1 (en) | 1999-10-25 | 2002-05-07 | Epicept Corporation | Local prevention or amelioration of pain from surgically closed wounds |
AU1623801A (en) * | 1999-11-19 | 2001-05-30 | Palatin Technologies, Inc. | Opioid metallopeptide compositions and methods |
AU2001239896A1 (en) * | 2000-03-16 | 2001-10-03 | Sepracor, Inc. | Peptidomimetic ligands for cellular receptors and ion channels |
AU8298801A (en) * | 2000-07-26 | 2002-02-05 | John K Vyden | Methods for treating atopic disorders |
BR0113055A (pt) * | 2000-08-08 | 2003-07-08 | Daiichi Seiyaku Co | Preparação sólida altamente absorvìvel |
US7057053B2 (en) | 2000-10-06 | 2006-06-06 | Cardiome Pharma Corp. | Ion channel modulating compounds and uses thereof |
US7524879B2 (en) | 2000-10-06 | 2009-04-28 | Cardiome Pharma Corp. | Ion channel modulating compounds and uses thereof |
US7181547B1 (en) | 2001-06-28 | 2007-02-20 | Fortinet, Inc. | Identifying nodes in a ring network |
US7655658B2 (en) * | 2001-08-10 | 2010-02-02 | Palatin Technologies, Inc. | Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds |
AU2002331064B2 (en) * | 2001-08-10 | 2007-08-23 | Palatin Technologies, Inc. | Peptidomimetics of biologically active metallopeptides |
US7718802B2 (en) | 2001-08-10 | 2010-05-18 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific piperazine compounds |
US7732451B2 (en) | 2001-08-10 | 2010-06-08 | Palatin Technologies, Inc. | Naphthalene-containing melanocortin receptor-specific small molecule |
US7456184B2 (en) * | 2003-05-01 | 2008-11-25 | Palatin Technologies Inc. | Melanocortin receptor-specific compounds |
US6638981B2 (en) * | 2001-08-17 | 2003-10-28 | Epicept Corporation | Topical compositions and methods for treating pain |
DE10252666A1 (de) * | 2002-11-11 | 2004-08-05 | Grünenthal GmbH | N-Piperidyl-cyclohexan-Derivate |
US7727990B2 (en) | 2003-05-01 | 2010-06-01 | Palatin Technologies, Inc. | Melanocortin receptor-specific piperazine and keto-piperazine compounds |
US7968548B2 (en) * | 2003-05-01 | 2011-06-28 | Palatin Technologies, Inc. | Melanocortin receptor-specific piperazine compounds with diamine groups |
US7727991B2 (en) | 2003-05-01 | 2010-06-01 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific single acyl piperazine compounds |
US7345086B2 (en) | 2003-05-02 | 2008-03-18 | Cardiome Pharma Corp. | Uses of ion channel modulating compounds |
DK1560812T3 (da) | 2003-05-02 | 2006-09-04 | Cardiome Pharma Corp | Aminocyclohexyletherforbindelser og anvendelser deraf |
WO2005018635A2 (en) | 2003-08-07 | 2005-03-03 | Cardiome Pharma Corp. | Ion channel modulating activity i |
US7345087B2 (en) | 2003-10-31 | 2008-03-18 | Cardiome Pharma Corp. | Aminocyclohexyl ether compounds and uses thereof |
CA2561819A1 (en) | 2004-04-01 | 2005-12-01 | Cardiome Pharma Corp. | Prodrugs of ion channel modulating compounds and uses thereof |
US8058304B2 (en) | 2004-04-01 | 2011-11-15 | Cardiome Pharma Corp. | Merged ion channel modulating compounds and uses thereof |
US7709484B1 (en) | 2004-04-19 | 2010-05-04 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific piperazine compounds |
US8263638B2 (en) | 2004-11-08 | 2012-09-11 | Cardiome Pharma Corp. | Dosing regimens for ion channel modulating compounds |
US7834017B2 (en) | 2006-08-11 | 2010-11-16 | Palatin Technologies, Inc. | Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents |
DE102007062550A1 (de) * | 2007-12-20 | 2009-06-25 | Westfälische Wilhelms-Universität Münster Körperschaft des öffentlichen Rechts | Perhydrochinoxalin-Derivate |
US9314524B2 (en) * | 2007-12-31 | 2016-04-19 | Calla Therapeutics Llc | Topical formulations of Flucytosine |
MX2015015755A (es) * | 2013-05-17 | 2016-03-11 | Wolff August Gmbh & Co Kg Arzneimittel Dr | Derivados de perhidroquinoxalina utiles como analgesicos. |
US9198898B2 (en) | 2013-06-24 | 2015-12-01 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
US8906951B1 (en) | 2013-06-24 | 2014-12-09 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
JP6369783B2 (ja) * | 2014-06-12 | 2018-08-08 | 株式会社アーダン | 加水分解フィブロインを含む軟膏及びその製造方法 |
US20210169848A1 (en) * | 2018-07-27 | 2021-06-10 | Vyne Therapeutics Inc. | Use of neurokinin-1 antagonists to treat pruritus |
EP3932390A1 (en) * | 2020-07-02 | 2022-01-05 | Dr. August Wolff GmbH & Co. KG Arzneimittel | Topical gel formulation containing asimadoline |
Family Cites Families (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4065573A (en) * | 1976-06-03 | 1977-12-27 | The Upjohn Company | 4-Amino-4-phenylcyclohexanone ketal compositions and process of use |
US4098904A (en) * | 1976-11-12 | 1978-07-04 | The Upjohn Company | Analgesic n-(2-aminocycloaliphatic)benzamides |
US4145435A (en) * | 1976-11-12 | 1979-03-20 | The Upjohn Company | 2-aminocycloaliphatic amide compounds |
US4212878A (en) * | 1978-01-26 | 1980-07-15 | The Upjohn Company | Phenylacetamide derivative analgesics |
DE3003303C2 (de) | 1980-01-30 | 1984-03-08 | Siemens AG, 1000 Berlin und 8000 München | Verfahren zur Mattierung von hochglänzenden Epoxidharzoberflächen bei Leiterplatten |
US4359476A (en) * | 1981-04-09 | 1982-11-16 | The Upjohn Company | Adjacently substituted cycloalkane-amide analgesics |
US4360531A (en) | 1981-04-09 | 1982-11-23 | The Upjohn Company | Substituted cycloalkanes |
US4466977A (en) | 1981-04-09 | 1984-08-21 | The Upjohn Company | N-[2-Amino(oxy- or thia- group-substituted-cycloaliphatic)]benzeneacetamides and -benzamide analgesics |
US4438130A (en) * | 1981-11-12 | 1984-03-20 | The Upjohn Company | Analgesic 1-oxa-, aza- and thia-spirocyclic compounds |
US4463013A (en) * | 1982-04-09 | 1984-07-31 | The Upjohn Company | Oxygen substituted amino-cyclohexyl-benzeneacetamides and -benzamides as water diuretic drugs |
US4656182A (en) * | 1983-12-06 | 1987-04-07 | Warner-Lambert Company | Substituted trans-1,2-diaminocyclohexyl amide compounds |
US4737493A (en) * | 1985-07-01 | 1988-04-12 | Warner-Lambert Company | 7-((substituted)amino)-8-((substituted)carbonyl)-methylamino)-1-oxaspiro(4,5)decanes as analgesic agents |
US4663343A (en) * | 1985-07-19 | 1987-05-05 | Warner-Lambert Company | Substituted naphthalenyloxy-1,2-diaminocyclohexyl amide compounds |
FR2592879B1 (fr) * | 1986-01-13 | 1988-04-29 | Roussel Uclaf | Nouveaux derives de la decahydroquinoleine, leur procede de preparation, les intermediaires de preparation, leur application a titre de medicaments et les compositions les renfermant |
GB8618188D0 (en) | 1986-07-25 | 1986-09-03 | Ici Plc | Diamine compounds |
US4876269A (en) | 1986-09-10 | 1989-10-24 | E. I. Du Pont De Nemours And Company | Benoz-fused cycloalkane trans-1,2-diamine derivatives |
MY101368A (en) | 1986-09-10 | 1991-09-05 | Bristol Myers Squibb Pharma Company | Benzo-fused cyclaolkane and oxa-and thai,cycloalkane trans-1, 2-daimine derivatives |
EP0261842B1 (en) | 1986-09-17 | 1990-11-22 | Dr. Lo. Zambeletti S.p.A. | N1-acylated-(1-(phenyl or benzyl))-1,2-ethylene diamines |
GB8801304D0 (en) | 1988-01-21 | 1988-02-17 | Ici Plc | Diamine compounds |
FR2627491B1 (fr) | 1988-02-18 | 1992-01-24 | Roussel Uclaf | Nouveaux derives du benzocyclohexane et du benzocycloheptane ainsi que leurs sels, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions les renfermant |
US4855316A (en) * | 1988-02-18 | 1989-08-08 | Warner-Lambert Company | 1,2-diamino-4,5-dimethoxycyclohexyl amide analgesic compounds |
JPH02138254A (ja) * | 1988-02-23 | 1990-05-28 | Glaxo Group Ltd | 複素環誘導体 |
GB8804014D0 (en) | 1988-02-23 | 1988-03-23 | Humphreys & Glasgow Ltd | Synthesis gas production |
GB8804104D0 (en) * | 1988-02-23 | 1988-03-23 | Glaxo Group Ltd | Chemical compounds |
KR890012970A (ko) | 1988-02-23 | 1989-09-20 | 추후보충 | 테트라히드로 이소퀴놀린 유도체 |
DE68923891T2 (de) | 1988-03-16 | 1996-02-22 | Smithkline Beecham Farm | Heterocyclische Derivate. |
DK247789A (da) | 1988-05-23 | 1989-11-24 | Glaxo Group Ltd | Piperazinderivater |
US5021413B1 (en) | 1988-08-24 | 1994-12-13 | Sankyo Co | Analgesic thiomorpholins, their preparation, and pharmaceutical compositions containing them |
GB8824400D0 (en) * | 1988-10-18 | 1988-11-23 | Glaxo Group Ltd | Chemical compounds |
AU626949B2 (en) * | 1988-12-06 | 1992-08-13 | Warner-Lambert Company | 2-amino-4 or 5-methoxycyclohexyl amides useful as analgesics |
DK626889A (da) | 1988-12-16 | 1990-06-17 | Roussel Uclaf | Indanderivater, deres fremstilling samt laegemidler med indhold deraf |
DE4034785A1 (de) | 1990-11-02 | 1992-05-07 | Merck Patent Gmbh | 1-(2-arylethyl)-pyrrolidine |
US5232978A (en) | 1988-12-23 | 1993-08-03 | Merck Patent Gesellschaft Mit Beschrankter Haftung | 1-(2-arylethyl)-pyrrolidines |
GB8830219D0 (en) | 1988-12-23 | 1989-02-22 | Zambeletti Spa L | Novel compounds |
US4906655A (en) * | 1989-01-24 | 1990-03-06 | Warner-Lambert Company | Novel 1,2-cyclohexylaminoaryl amides useful as analgesic agents |
US4965278A (en) | 1989-04-21 | 1990-10-23 | Warner-Lambert Company | 7-(substituted)amino)-8-((substituted)carbonyl)-methylamino)-1-oxaspiro[4,5]decanes as diuretics antiiflammatory, and cerebrovascular agents |
CA2017020A1 (en) | 1989-05-18 | 1990-11-18 | Alan Naylor | Chemical compounds |
GB8916395D0 (en) | 1989-07-18 | 1989-09-06 | Zambeletti Spa L | Pharmaceuticals |
WO1992020657A1 (en) * | 1991-05-21 | 1992-11-26 | Smithkline Beecham Farmaceutici S.P.A. | 2-(pyrrolidinyl-1-methyl)-piperidine derivatives and their use as kappa-recept or agonists |
US6323212B1 (en) | 1992-01-23 | 2001-11-27 | Toray Industries, Inc. | Morphinan derivative and its pharmaceutical applications |
DE4215213A1 (de) | 1992-05-09 | 1993-11-11 | Merck Patent Gmbh | Arylacetamide |
US5475019A (en) | 1993-02-08 | 1995-12-12 | East Carolina University | Method of treating anxiety-related disorders with 2-aminocycloaliphatic amide compounds |
WO1994018165A1 (en) | 1993-02-12 | 1994-08-18 | Pfizer Inc. | Sulfonamide compounds as opioid k-receptor agonists |
EP0663401B1 (en) | 1993-07-23 | 2000-06-07 | Toray Industries, Inc. | Morphinan derivative and medicinal use |
WO1996006078A1 (en) | 1994-08-24 | 1996-02-29 | Pfizer Pharmaceuticals Inc. | N-(2-(pyrrolidinyl-1)-1-phenylethyl)acetamides as kappa receptor antagonists |
US5610271A (en) | 1995-06-07 | 1997-03-11 | Torrey Pines Institute For Molecular Studies | Kappa receptor selective opioid peptides |
DE19523502A1 (de) | 1995-06-28 | 1997-01-02 | Merck Patent Gmbh | Kappa-Opiatagonisten für entzündliche Darmerkrankungen |
US5804595A (en) | 1995-12-05 | 1998-09-08 | Regents Of The University Of Minnesota | Kappa opioid receptor agonists |
US5763445A (en) | 1996-03-08 | 1998-06-09 | Adolor Corporation | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
US5646151A (en) * | 1996-03-08 | 1997-07-08 | Adolor Corporation | Kappa agonist compounds and pharmaceutical formulations thereof |
US5688955A (en) * | 1996-03-08 | 1997-11-18 | Adolor Corporation | Kappa agonist compounds and pharmaceutical formulations thereof |
US6057323A (en) | 1996-03-08 | 2000-05-02 | Adolor Corporation | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
US6239154B1 (en) * | 1996-03-08 | 2001-05-29 | Adolor Corporation | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
US6303611B1 (en) | 1996-03-08 | 2001-10-16 | Adolor Corporation | Kappa agonist compounds and pharmaceutical formulations thereof |
US5888494A (en) | 1996-03-12 | 1999-03-30 | Adolor Corporation | Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith |
DE69732868T2 (de) | 1996-11-25 | 2006-04-13 | Toray Industries, Inc. | Mittel gegen Juckreiz |
US5760023A (en) | 1997-07-14 | 1998-06-02 | Adolor Corporation | Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
US5849762A (en) | 1997-07-14 | 1998-12-15 | Adolor Corporation | Peripherally acting anti-pruritic opiates |
WO1999003459A1 (en) | 1997-07-14 | 1999-01-28 | Adolor Corporation | Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
FR2766205B1 (fr) | 1997-07-16 | 2002-08-30 | Inst Nat Sante Rech Med | Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede |
AU2001284665B2 (en) * | 2000-07-21 | 2006-06-08 | Revance Therapeutics, Inc. | Multi-component Biological Transport Systems |
-
1997
- 1997-07-14 US US08/891,833 patent/US5763445A/en not_active Expired - Fee Related
-
1998
- 1998-03-21 US US09/045,522 patent/US5981513A/en not_active Expired - Fee Related
- 1998-06-19 AU AU79801/98A patent/AU725232B2/en not_active Ceased
- 1998-06-19 NZ NZ513889A patent/NZ513889A/xx not_active Application Discontinuation
- 1998-06-19 WO PCT/US1998/012769 patent/WO1999003468A1/en not_active Application Discontinuation
- 1998-06-19 NZ NZ500439A patent/NZ500439A/en unknown
- 1998-06-19 CA CA002289055A patent/CA2289055A1/en not_active Abandoned
- 1998-06-19 BR BR9810712-7A patent/BR9810712A/pt not_active Application Discontinuation
- 1998-06-19 KR KR1020007000417A patent/KR20010021853A/ko not_active Application Discontinuation
- 1998-06-19 IL IL13238898A patent/IL132388A0/xx unknown
- 1998-06-19 JP JP2000502767A patent/JP2001510154A/ja active Pending
- 1998-06-19 EP EP98930400A patent/EP0998281A1/en not_active Withdrawn
- 1998-07-13 ZA ZA986208A patent/ZA986208B/xx unknown
-
1999
- 1999-05-07 US US09/307,517 patent/US6028063A/en not_active Expired - Fee Related
- 1999-11-08 US US09/436,057 patent/US6180623B1/en not_active Expired - Lifetime
- 1999-12-20 NO NO996352A patent/NO996352L/no not_active Application Discontinuation
-
2001
- 2001-01-26 US US09/769,450 patent/US20020042399A1/en not_active Abandoned
-
2003
- 2003-06-05 US US10/455,545 patent/US7294647B2/en not_active Expired - Fee Related
- 2003-06-05 US US10/455,687 patent/US6960612B2/en not_active Expired - Fee Related
-
2005
- 2005-09-14 NO NO20054249A patent/NO20054249L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20040220112A1 (en) | 2004-11-04 |
EP0998281A1 (en) | 2000-05-10 |
US6960612B2 (en) | 2005-11-01 |
JP2001510154A (ja) | 2001-07-31 |
AU725232B2 (en) | 2000-10-12 |
US5763445A (en) | 1998-06-09 |
IL132388A0 (en) | 2001-03-19 |
ZA986208B (en) | 1999-01-25 |
NZ513889A (en) | 2001-09-28 |
US6180623B1 (en) | 2001-01-30 |
US6028063A (en) | 2000-02-22 |
US5981513A (en) | 1999-11-09 |
NO996352D0 (no) | 1999-12-20 |
BR9810712A (pt) | 2000-09-05 |
CA2289055A1 (en) | 1999-01-28 |
NO20054249L (no) | 2000-03-13 |
WO1999003468A1 (en) | 1999-01-28 |
AU7980198A (en) | 1999-02-10 |
NZ500439A (en) | 2001-10-26 |
US7294647B2 (en) | 2007-11-13 |
KR20010021853A (ko) | 2001-03-15 |
US20020042399A1 (en) | 2002-04-11 |
US20030236248A1 (en) | 2003-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO996352L (no) | Kappaagonistforbindelser, farmasøytiske formuleringer og metode for forhindring og behandling av kløe med disse | |
NO996353L (no) | Farmasøytiske antikløe-formuleringer som inneholder kappaagonister og metode for behandling av kløe med disse | |
NO984107L (no) | Kappa-agonist-forbindelser og farmas°ytiske preparater derav | |
NO973479L (no) | Substituerte heterosykliske forbindelser, fremgangsmåte for fremstilling og farmasöytiske blandinger inneholdende samme | |
ZA986206B (en) | Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith | |
NO980055D0 (no) | Antisoppmiddel, forbindelse derfor og fremgangsmåte for fremstilling derav | |
NO20003096D0 (no) | Sammensetninger og fremgangsmÕter for behandling av ADD | |
PL330841A1 (en) | Benzosulphonic derivatives, method of obtaining them and therapeutic agents containing such derivatives | |
NO20000227L (no) | Krystallmodifikasjon av et N-fenyl-2-pyrimidinaminderivat, fremgangsmåte for dens fremstilling og dens anvendelse | |
NO972687L (no) | Utskyllingslösning og fremgangsmåte for inhibering av smerte, inflammasjon og spasmer | |
PL317930A1 (en) | Oxalydine compounds, method of obtaining them and therapeutic agents | |
NO20004896D0 (no) | Pyridazinonhydrokloridforbindelse og fremgangsmÕte for fremstilling derav | |
NO985484L (no) | FremgangsmÕte og preparat for behandling og forhindring av hyperurikemi | |
NO20003070L (no) | Substituert tiazolidinderivat, fremgangsmÕte for fremstilling og anvendelse derav | |
NO20003234L (no) | Oralt administrerbare ribavirindoseformer i fast form og fremgangsmÕte for fremstilling av disse | |
NO20012963D0 (no) | Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler | |
DK1071433T3 (da) | 2',2'-difluornucleosider til immunosuppressiv behandling og kombinationspræparater | |
NO20002181D0 (no) | Steriliseringsinnpakning, anvendelse derav og fremgangsmÕte for sterilisering | |
DK1003383T4 (da) | Smagsforstærkende N-ethyl-p-menthan-3-carboxamidindeholdende forbindelser og fremgangsmåde til fremstilling og anvendelse deraf | |
FI991211A0 (fi) | Menetelmä ja laitteisto massan käsittelemiseksi | |
DK0838469T3 (da) | 10,13,15-trioxatricyclo(9.2.1 9.6)-pentadecanon-derivater, fremgangsmåde til deres fremstilling og lægemidler indeholdende disse forbindelser | |
NO20000706D0 (no) | Metode for økning av biotilgjengeligheten av feksofenadin og dens derivater | |
BR9505995A (pt) | Composto método para tratamentos e composição farmacêutica | |
GB2344586B (en) | Isoquinuclidine derivatives,method of manufacturing the same and therapeutic agents for hypercholesterolemia containing these compounds | |
NO996467L (no) | FremgangsmÕte for fremstilling av tiazofurin og andre C- nukleosider |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |